ArticleBlood advances2026

Dynamic monitoring of circulating cell-free EBV-DNA for risk assessment in early-stage natural killer/T-cell lymphoma.

Zegeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.